Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis

dc.citation.epage591pt_BR
dc.citation.issue9pt_BR
dc.citation.spage588pt_BR
dc.citation.volume76pt_BR
dc.creatorBranco, Luciana Prats
dc.creatorAdoni, Tarso
dc.creatorApostolos-Pereira, Samira Luisa
dc.creatorBrooks, Joseph Bruno Bidin
dc.creatorCorrea, Eber Castro
dc.creatorDamasceno, Carlos Augusto
dc.creatorEboni, Audred Cristina Biondo
dc.creatorFezer, Leticia
dc.creatorGama, Paulo Diniz da
dc.creatorGoncalves, Marcus Vinicius Magno
dc.creatorGomes, Sidney
dc.creatorGrzesiuk, Anderson Kuntz
dc.creatorMendes, Maria Fernanda
dc.creatorMorales, Rogerio Rizo
dc.creatorMuniz, Andre
dc.creatorParolin, Monica Fiuza Koncke
dc.creatorPimentel, Maria Lucia Vellutini
dc.creatorRibeiro, Marlise de Castro
dc.creatorSantos, Gutemberg Augusto Cruz dos
dc.creatorSato, Henry Koiti
dc.creatorScherpenhuijzen, Simone Batista
dc.creatorScorcine, Claudio
dc.creatorSiquineli, Fabio
dc.creatorSousa, Nise Alexandra de Carvalho
dc.creatorVarela, Daniel Lima
dc.creatorWinckler, Tereza Cristina Avila
dc.creatorFragoso, Yara Dadalti
dc.date.accessioned2019-02-27T15:01:45Z
dc.date.available2019-02-26
dc.date.available2019-02-27T15:01:45Z
dc.date.issued2018-09
dc.description.abstractTreatment options for multiple sclerosis (MS) have changed over the last few years, bringing about a new category of drugs with more efficient profiles. However, these drugs have come with a whole new profile of potential adverse events that neurologists have to learn well and quickly. One of the most feared complications of these MS treatments is progressive multifocal leukoencephalopathy caused by the reactivation of the John Cunningham virus (JCV). Objective: To identify the serologic profile of JCV in patients with MS. Methods: Data on serum antibodies for JCV were obtained using the enzyme-linked immunosorbent assay provided by the STRATIFY-JCV program. Results: A total of 1,501 blood tests were obtained from 1,102 patients with MS. There were 633 patients (57.1%) who were positive for antibodies for JCV and 469 patients who were negative (42.9%). Twenty-three patients became positive after initially having negative JCV antibody status. The rate of seroconversion was 18.5% over 22 months. Conclusion: The JCV serologic profile and seroconversion in Brazilian patients were similar to those described in other countries.pt_BR
dc.description.resumoAs opçÔes terapĂȘuticas para esclerose mĂșltipla (EM) modificaram-se ao longo dos Ășltimos anos, trazendo uma nova categoria de drogas com melhor perfil de eficĂĄcia. No entanto, estas drogas vieram com um novo perfil de potenciais eventos adversos que exigem que o neurologista os reconheça bem e rapidamente. Uma das complicaçÔes mais temidas destes tratamentos para a EM Ă© a leucoencefalopatia multifocal progressiva (LEMP), causada pela reativação do vĂ­rus John Cunningham (JCV). Objetivo: Identificar o perfil sorolĂłgico de JCV em pacientes com EM. MĂ©todos: Dados sorolĂłgicos de JCV foram obtidos atravĂ©s do ensaio por enzimas imuno-adsorvidas (ELISA) fornecido pelo programa STRATIFY-JCV. Resultados: Um total de 1.501 testes sanguĂ­neos foram obtidos de 1.102 pacientes com EM. O grupo teve 633 pacientes (57,1%) soropositivos para anticorpos anti-JCV e 469 pacientes negativos (42,9%). Vinte e trĂȘs pacientes se tornaram posivitos apĂłs resultados iniciais negativos para anticorpos anti-JCV. A taxa de soroconversĂŁo foi 18,5% em 22 meses. ConclusĂŁo: O perfil sorolĂłgico do JCV e a soroconversĂŁo nos pacientes brasileiros foi semelhante Ă quela descrita em outros paĂ­ses.pt_BR
dc.identifier.doihttp://dx.doi.org/10.1590/0004-282x20180083pt_BR
dc.identifier.urihttps://repositorio.ufjf.br/handle/ufjf/9232
dc.languageengpt_BR
dc.publisher-pt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.initials-pt_BR
dc.relation.ispartofArquivos de Neuro-Psiquiatriapt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectEsclerose mĂșltiplapt_BR
dc.subjectLeucoencefalopatia multifocal progressivapt_BR
dc.subjectVĂ­rus JCpt_BR
dc.subjectNatalizumabpt_BR
dc.subjectMultiple sclerosispt_BR
dc.subjectLeukoencephalopathypt_BR
dc.subjectProgressive multifocalpt_BR
dc.subjectJC viruspt_BR
dc.subjectNatalizumabpt_BR
dc.subject.cnpq-pt_BR
dc.titleSerological profile of John Cunningham virus (JCV) in patients with multiple sclerosispt_BR
dc.title.alternativePerfil sorolĂłgico do vĂ­rus John Cunningham (JCV) em pacientes com esclerose mĂșltiplapt_BR
dc.typeArtigo de PeriĂłdicopt_BR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis.pdf
Size:
94.35 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.15 KB
Format:
Item-specific license agreed upon to submission
Description: